GLP-1 and GIP medications, like Mounjaro/Zepbound (tirzepatide) and Wegovy/Ozempic (semaglutide), are the newest “game-changing” weight loss medications everyone is talking about!   What are they? What are the differences? Which one is more effective?   Both medications belong to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are used diabetes management and weight loss. They are

Mounjaro/Zepbound (tirzepatide) and Wegovy/Ozempic (semaglutide), are GLP-1 and GIP medications, the newest weight loss medications getting a lot of attention lately. What are they? What are the differences? Which one is more effective?   These medications belong to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are used for diabetes management and weight loss.    These

GLP-1 and GIP medications, like Mounjaro/Zepbound (tirzepatide) and Wegovy/Ozempic (semaglutide), have been in the news and on social media due to the dramatic weight loss seen by many people.   First check with your insurance company and see if they cover weight loss medications like Wegovy or Zepbound. If your insurance does not cover weight loss medications, you could consider

These GLP-1 medications are generally well-tolerated but may cause fatigue, headaches, hair loss, and gastrointestinal side effects such as nausea, vomiting, acid reflux, diarrhea, upset stomach, abdominal pain, and/or constipation, especially when starting treatment. These side effects usually diminish over time as the body adjusts to the medication. There can also be injection-site reactions (such as redness, swelling, itching or